Felix Health vs MyRocky: Which GLP-1 Program Wins in Canada?

Felix Health wins the entry price and loses the year. A $0 initial consultation against MyRocky’s $99 is a real difference on day one, and it is the last point at which Felix is the cheaper of the two for a patient who does not specifically need brand-name medication.

The reason is dose escalation. Semaglutide is titrated upward over the first months of treatment, and brand-name pricing rises with each step. Generic pricing from $149 a month holds far flatter across the same titration, so the two lines separate over a year rather than converge. A $99 one-time fee is recovered inside the first billing cycle against brand-name pricing and does not recur.

Compare the all-in twelve-month cost at your target dose, in CAD, before you enrol with either. That is the number that reflects what you actually pay, and it is the only comparison on which these two programs genuinely differ.

Telehealth is regulated provincially in Canada, not federally, and Quebec runs its own regime through the Collège des médecins du Québec. Several national platforms have not built for it. Felix Health does not currently serve Quebec.

MyRocky does. For a Quebec resident that settles this before price, pharmacy model or medication range enters into it — one of the two options is not available to you at all. Neither platform serves Yukon, the Northwest Territories or Nunavut, which is standard across national Canadian telehealth rather than specific to either company.

Neither platform bills private insurance directly. Both issue itemized receipts that you submit yourself, so reimbursement sits between you and your plan rather than being something either provider can promise you at checkout.

What comes back depends on your plan and your indication far more than on which provider you chose. Private plans reimburse a GLP-1 prescribed for type 2 diabetes considerably more often than one prescribed for weight management, and prior authorization is common either way. Provincial public drug plans generally do not cover a GLP-1 prescribed for weight loss alone.

If reimbursement is central to your decision, get the answer from your insurer before you enrol, not after. It will not change which of these two is the better program, but it can change what the year costs you by more than the gap between them.

Neither platform locks you into a contract, and a prescription is not tied to a single telehealth provider. Most people switching are doing it for one of three reasons: they have moved to Quebec, they want generic pricing instead of brand-name, or they want the prescription and the dispensing handled by one organization.

The mechanics are straightforward. Complete the new provider’s intake, state your current medication, your current dose and how long you have been on it, and their clinician decides independently whether to continue you at that dose or adjust it. Recent bloodwork is the single thing most likely to shorten the wait.

The one thing worth planning is supply. Do not let your current prescription lapse while the new intake is under review. A gap long enough to lose tolerance means re-titrating from a lower dose, which costs weeks and undoes the saving that prompted the switch.